Changes in intestinal fungal diversity and compositions in patients with cholestatic liver disease

Changes in intestinal fungal diversity and compositions in patients with cholestatic liver disease

Objective To analyze the changes in intestinal fungi and compositions in patients with cholestatic liver disease from healthy individuals. Methods Fresh feces from 20 patients with cholestatic liver disease and 22 healthy individuals were collected. The intestinal fungi were determined by ITS2 DNA s...

Full description

Bibliographic Details
Main Authors:	LI Zhen, YANG Guodong, TANG Bo, TANG Li
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Army Medical University 2022-06-01
Series:	陆军军医大学学报
Subjects:	cholestatic liver disease fungi its2 dna
Online Access:	http://aammt.tmmu.edu.cn/Upload/rhtml/202202023.htm

Similar Items

Gut microbiome in liver pathophysiology and cholestatic liver disease
by: Shengmin Yan, et al.
Published: (2021-09-01)

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease
by: Rina Li, et al.
Published: (2023-10-01)

Alpha-ketoglutarate alleviates cholestatic liver injury in mice
by: XIE Yuhong, et al.
Published: (2022-07-01)

Characteristics of gut microbiota and their correlation with clinical parameters in patients with cholestatic liver disease
by: WU Lingyi, et al.
Published: (2020-11-01)

The Role of Inflammation in Cholestatic Liver Injury
by: Chen J, et al.
Published: (2023-10-01)

Pruritus in chronic cholestatic liver diseases
by: E. V. Vinnitskaya, et al.
Published: (2017-12-01)

Effect of Vitamin B5 on Liver Enzyme Levels in Bile Duct Ligation Cholestatic Rat Model
by: Fatemeh Sadat Emami, et al.
Published: (2017-01-01)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
by: Qingmiao Shi, et al.
Published: (2023-05-01)

Quality of life among patients suffering from cholestatic liver disease-induced pruritus: A systematic review
by: Xin Yee Jin, et al.
Published: (2016-09-01)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
by: Bo Wu, et al.
Published: (2022-06-01)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Lisheng Chen, et al.
Published: (2021-08-01)

Secondary Malnutrition and Nutritional Intervention in Cholestatic Liver Diseases in Infants
by: Alfredo Larrosa-Haro, et al.
Published: (2021-11-01)

New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?
by: Panteleimon E. Papakonstantinou, et al.
Published: (2017-07-01)

Reversine attenuates cholestatic ductular reaction in rats
by: Di Huang, et al.
Published: (2023-05-01)

Tamoxifen Ameliorates Cholestatic Liver Fibrosis in Mice: Upregulation of TGFβ and IL6 Is a Potential Protective Mechanism
by: Dino Šisl, et al.
Published: (2022-05-01)

Cholestatic Liver Injury in a Patient with Tertiary Syphilis
by: Sahaj Mujumdar, et al.
Published: (2022-09-01)

Single-Cell Transcriptomes Reveal Characteristic Features of Mouse Hepatocytes with Liver Cholestatic Injury
by: Na Chang, et al.
Published: (2019-09-01)

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice
by: Zhenya Guo, et al.
Published: (2022-01-01)

Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
by: Linzhang Zhang, et al.
Published: (2022-10-01)

Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults
by: Lili Cao, et al.
Published: (2024-04-01)

Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves’s disease: a case report and literature review
by: Jinhui Zeng, et al.
Published: (2021-09-01)

Cholestatic hepatitis induced by atorvastatin: a case-report
by: M. Vergura, et al.
Published: (2013-05-01)

Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling
by: Huiling Cao, et al.
Published: (2024-01-01)

Evaluation of the use of laparoscopic-guided cholecystocholangiography and liver biopsy in definitive diagnosis of neonatal cholestatic jaundice
by: Khalid Shreef, et al.
Published: (2016-01-01)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
by: Shuailing Song, et al.
Published: (2023-05-01)

Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease
by: Juan Hao, et al.
Published: (2023-07-01)

First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder
by: Nawal Al Nahdi, et al.
Published: (2013-01-01)

Ketamine restriction correlates with reduced cholestatic liver injury and improved outcomes in critically ill patients with burn injury
by: Christian De Tymowski, et al.
Published: (2024-02-01)

Cholestatic Liver Disease and Pregnancy: A Systematic Review and Meta-Analysis
by: Bryan Ferrigno, et al.
Published: (2022-02-01)

A Case Report on Cholestatic Jaundice Secondary to Adverse Effect of Phaleria macrocarpa (Mahkota Dewa)
by: Muhammad Firdaus Abdul Rahim, et al.
Published: (2019-10-01)

The Role of Mesothelin in Activation of Portal Fibroblasts in Cholestatic Liver Injury
by: Takahiro Nishio, et al.
Published: (2022-10-01)

Heme Oxygenase-1 Induction by Cobalt Protoporphyrin Ameliorates Cholestatic Liver Disease in a Xenobiotic-Induced Murine Model
by: Jung-Yeon Kim, et al.
Published: (2021-07-01)

Protective Effects of Bee Venom-Derived Phospholipase A<sub>2</sub> against Cholestatic Liver Disease in Mice
by: Jung-Yeon Kim, et al.
Published: (2021-08-01)

Cholestatic jaundice in a sample of Iraqi Infants (A hospital based study)
by: Sawsan I. Al-Azzawi, et al.
Published: (2011-04-01)

Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report
by: Harsha Moole, et al.
Published: (2015-10-01)

JCAD, a new potential therapeutic target in cholestatic liver disease
by: Byoung Kuk Jang
Published: (2024-04-01)

Causal associations between gut microbiota and Cholestatic liver diseases: a Mendelian randomization study
by: Jiaqi Yang, et al.
Published: (2024-01-01)

Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
by: Antonia Greimel, et al.
Published: (2023-11-01)

The Role of Gut Microbiota in Mice With Bile Duct Ligation-Evoked Cholestatic Liver Disease-Related Cognitive Dysfunction
by: Bowen Yang, et al.
Published: (2022-05-01)

Induced Endothelial Cell-Integrated Liver Assembloids Promote Hepatic Maturation and Therapeutic Effect on Cholestatic Liver Fibrosis
by: Donggyu Nam, et al.
Published: (2022-07-01)